Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2545–2568 of 6,936 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Crohn's Disease, Ulcerative Colitis (UC), Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)
Interventions: Empowered Relief, Living Better with Chronic Pain; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Pelvic Pain, Interstitial Cystitis, Post Traumatic Stress Disorder, Fibromyalgia, Irritable Bowel Syndrome
Interventions: tDCS; Procedure
Lead sponsor: Summa Health System; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Akron, Ohio

Conditions: Infections, Pneumonia
Interventions: Ceftaroline fosamil, IV Ceftriaxone and Vancomycin; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 2 Months to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 13
States / cities: Long Beach, California • Oakland, California • Orange County, California + 10 more

Conditions: Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Interventions: Drug Eluting Balloon, Drug eluting stent, Plain old balloon angioplasty; Device · Procedure
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 1,616 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 48
States / cities: Scottsdale, Arizona • Jonesboro, Arkansas • La Jolla, California + 40 more

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: AID system with Remote Real-Time CGM, Standard of Care Insulin Therapy + CGM; Device · Combination Product
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 3
States / cities: Stanford, California • Atlanta, Georgia • Charlottesville, Virginia

Conditions: Neuropathy, Paraneoplastic
Interventions: MC-5A, Sham device; Device · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Joint Disease
Interventions: Mini Stem, Nano; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 12
States / cities: Scottsdale, Arizona • Fort Lauderdale, Florida • Fort Wayne, Indiana + 9 more

Conditions: Small Cell Lung Carcinoma
Interventions: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Carboplatin, Etoposide, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 503 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 22
States / cities: Fort Myers, Florida • Orlando, Florida • St. Petersburg, Florida + 18 more

Conditions: Parenting, Child Behavior, Child Rearing
Interventions: Triple P-Level 2, Play Nicely, Usual care; Other
Lead sponsor: Tulane University; Other
Eligibility: 2 Years and older
Enrollment: 1,133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)
Interventions: FS VH S/D 500 s-apr, 60-seconds polymerization time, FS VH S/D 500 s-apr, 120-seconds polymerization time, Manual compression with surgical gauze pads; Biological · Procedure
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: Not listed
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 11
States / cities: Birmingham, Alabama • Tucson, Arizona • Long Beach, California + 8 more

Conditions: Heart Arrest, Implantable Defibrillator User, Physical Activity
Interventions: E-ICD Intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: HIV, STI, Emotional Disturbances, Mental Disorder
Interventions: HIV/STI Prevention Intervention, General Health Control Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 14 Years to 17 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: iHealth Wireless Blood Pressure Monitor; Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Contraception
Interventions: Interaction with users of IUC and non-IUC users, Interaction with non-IUC users only; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 630 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Arthroplasty, Replacement, Knee, Sleep Initiation and Maintenance Disorders
Interventions: Melatonin 5 mg, Placebo (Vitamin C); Dietary Supplement
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Nicotine Dependence
Interventions: Motivational Interviewing, Psychoeducation; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Shoulder Injuries, Shoulder Pain
Interventions: Active Rehabilitation Program (ARP), Nonspecific Passive Intervention (NPI); Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pain Management
Interventions: video-guided acupuncture imagery treatment (VGAIT), Education video; Other
Lead sponsor: Jingping Wang, MD, Ph.D.; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pain Management, Abortion, Second Trimester Abortion, Dilation and Evacuation
Interventions: Ketorolac, oral ibuprofen, Placebo, Lidocaine HCl 1%, Saline; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression
Interventions: Supportive Therapy SSI, Behavioral Activation SSI, Growth Mindset SSI; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 13 Years to 16 Years
Enrollment: 2,452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: OCD
Interventions: CBM-TAF, CBM-SMP; Behavioral
Lead sponsor: Han Joo Lee; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Small Cell Lung Cancer (SCLC)
Interventions: Pembrolizumab, Normal saline solution, Carboplatin, Cisplatin, Etoposide; Biological · Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 453 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 27
States / cities: Miami, Florida • Chicago, Illinois • Evanston, Illinois + 21 more

Conditions: Non-Small Cell Lung Cancer
Interventions: pictilisib, Placebo, bevacizumab, carboplatin, paclitaxel; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 44
States / cities: Birmingham, Alabama • Rogers, Arkansas • Encinitas, California + 37 more

Conditions: Obesity
Interventions: PSD Veritas Collagen Matrix, Roux-en-Y gastric by-pass surgery with no buttress; Device · Procedure
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Columbia, Missouri

Search by objective public record fields.

Online Pain Education for Crohn's Disease and Ulcerative Colitis

Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Automated Insulin Delivery for Inpatients With Dysglycemia

MC-5A for Chemotherapy Induced Peripheral Neuropathy

Comprehensive Shoulder System Nano IDE

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Longitudinal Follow-up of Brief Parenting Interventions to Reduce Risk of Child Physical Maltreatment

Fibrin Sealant Vascular Surgery Study

Effectiveness of Exercise After an ICD

HIV/STI Prevention Among Black Adolescents With Mental Illnesses (Project GOLD)

Assessing Blood Pressure Remotely in Childhood Cancer Survivors

Online Peer Influence on IUD Behaviors and Attitudes

TKA Melatonin and Sleep Quality

Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI

Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial

Imagined Acupuncture for Postoperative Pain After Spinal Surgery

Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement

Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19

Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix